Start with its own history
At 16.09×, BDX is 75.5% below its 10-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
NYSE · BDXMedical - Instruments & SuppliesUpdated Nov 4, 2026
Becton, Dickinson and Company P/E ratio
Current valuation, historical context, and peer comparisons.
Current P/E ratio
16.09×
75.5% belowthe 10-year annual average
Share price209.19
÷Earnings per share13
Price and EPS in quote currency. Calculation details
Investors are paying 16.09 for every 1 of reported earnings per share.
P/E over time
2016 – 2025
Annual P/ESelected-period average 65.81×
3-year average32.78×3 positive annual observations
5-year average31.02×5 positive annual observations
10-year average65.81×10 positive annual observations
Peer median · TTM38.24×6 peers with positive P/E
Historical P/E ratios
Annual period-end data · 25 observations
| Period end | P/E | Change |
|---|---|---|
| Sep 30, 2025 | 25.20× | -21.8% |
| Sep 30, 2024 | 32.23× | -21.2% |
| Sep 30, 2023 | 40.90× | +38.4% |
| Sep 30, 2022 | 29.54× | +8.4% |
| Sep 30, 2021 | 27.25× | -58.0% |
| Sep 30, 2020 | 64.89× | +32.5% |
| Sep 30, 2019 | 48.99× | -85.0% |
| Sep 30, 2018 | 327.06× | +922.8% |
View all 25 annual observations +
| Period end | P/E | Change |
|---|---|---|
| Sep 30, 2017 | 31.98× | +6.5% |
| Sep 30, 2016 | 30.03× | +1.2% |
| Sep 30, 2015 | 29.66× | +108.3% |
| Sep 30, 2014 | 14.24× | +23.1% |
| Sep 30, 2013 | 11.57× | +6.8% |
| Sep 30, 2012 | 10.83× | +10.7% |
| Sep 30, 2011 | 9.78× | -3.3% |
| Sep 30, 2010 | 10.11× | -3.2% |
| Sep 30, 2009 | 10.45× | -21.7% |
| Sep 30, 2008 | 13.35× | -23.6% |
| Sep 30, 2007 | 17.49× | -1.9% |
| Sep 30, 2006 | 17.83× | +27.3% |
| Sep 30, 2005 | 14.01× | -34.6% |
| Sep 30, 2004 | 21.43× | +65.6% |
| Sep 30, 2003 | 12.94× | +9.9% |
| Sep 30, 2002 | 11.77× | -35.2% |
| Sep 30, 2001 | 18.16× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
How BDX compares
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
 BDX This stockBecton, Dickinson and Company | 16.09× |
 ICUIICU Medical, Inc. | 143.85× |
 WSTWest Pharmaceutical Services, Inc. | 45.57× |
 SOLVSolventum Corporation | 10.87× |
 TFXTeleflex Incorporated | N/M |
 MMSIMerit Medical Systems, Inc. | 33.69× |
 BAXBaxter International Inc. | N/M |
 MDTMedtronic Plc | 25.66× |
 ABTAbbott Laboratories | 42.78× |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
What does BDX’s P/E tell you?
Compare like with like
The median of the 6 positive peer ratios above is 38.24×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
Check what drives earnings
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Take BDX into your spreadsheet
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore WisesheetsQuarterly P/E · latest quarterLQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data
=WISE("BDX", "PE Ratio", "LQ")Sources & calculation methodology
Current P/E
Share price 209.19 ÷ EPS 13 = 16.09×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 4, 2026; this is not a real-time trading quote.
History & averages
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
Data definitions and limitations
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
BDX P/E ratio: common questions
The essentials behind the numbers.
Becton, Dickinson and Company's current P/E is 16.09× based on the quote data last updated Nov 4, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.